In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 110 for your search:
Drug:  pegfilgrastim
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ACCOG-SCTN-BR0101, SCTN-BR0101, EU-20143, NCT00030758

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2006-003750-23, LINFOTARGAM, NCT00466258

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: AMLSG07-04, NCT00151242

4.

Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NEUGR-002, NCT00837265

5.

Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GCPGC P2/3, NCT01328938

6.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 25 and under at diagnosis
Sponsor: NCI
Protocol IDs: NCI-00-C-0092, AMGEN-20000124, NCT00020137

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: GOG-0184, ECOG-G0184, RTOG-EN0130, CDR0000068020, NCI-2012-02350, NCT00006011

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 60
Sponsor: Other
Protocol IDs: EORTC-20012, GELA-EORTC-20012, BNLI-EORTC-20012, GELCAB-EORTC-20012, NORDICLG-EORTC-20012, CAN-NCIC-EORTC-20012, ALLG-HD04, 2004-001558-10, hd8, NCT00049595

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: Other
Protocol IDs: EORTC-62012, NCT00061984

10.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000334899, S0221, U10CA032102, SWOG-S0221, NCT00070564

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000463447, ICR-TACT2, EU-205114, EUDRACT-2004-000066-13, MREC-04/MRE00/88, ISRCTN68068041, NCT00301925

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: GIM-2, EU-20681, NCT00433420

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: Other
Protocol IDs: IIL-DLCL04, EudraCT number 2007-000275-42, NCT00499018

14.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: 70 and over
Sponsor: Other
Protocol IDs: UKM-CCH-ACTION, ICR-CTSU/2006/10004-ACTION, EU-20751, EUDRACT-2005-005721, ISRCTN41708421, BIG-205, BIG 2-05, NCT00516425

15.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other
Protocol IDs: CRUK-2007-006064-30, 2007-006064-30, CRUK-07/146, NCT00678327

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: NSABP B-46-I, USOR 07132, NCT00887536

17.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20080259, NCT00911170

18.

Phase: Phase III
Type: Tissue collection/Repository, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2010-01738, CDR0000659024, GOG-0250, U10CA027469, NCT01012297

19.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NEUGR-003, NCT01126190

20.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: LA-EP06-302, NCT01516736

21.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: HHPG-19K -III-01, NCT01611051

22.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: DA3031_NP_III, NCT01674855

23.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: LA-EP06-301, 2011-004532-58, NCT01735175

24.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: Other
Protocol IDs: MA22, CAN-NCIC-MA22, CDR0000316237, NCT00066443

25.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02600, 12975A, N01CM62201, CDR0000371904, UCCRC-12975A, 6243, NCI-6243, NCT00086944
1     
New Search